Your browser doesn't support javascript.
loading
Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.
Sayre, Mikko; Lapham, Gwen T; Lee, Amy K; Oliver, Malia; Bobb, Jennifer F; Caldeiro, Ryan M; Bradley, Katharine A.
Afiliación
  • Sayre M; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA. mns2144@cumc.columbia.edu.
  • Lapham GT; Columbia-Bassett Program at Columbia University College of Physicians and Surgeons, Cooperstown, NY, USA. mns2144@cumc.columbia.edu.
  • Lee AK; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Oliver M; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Bobb JF; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Caldeiro RM; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Bradley KA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
J Gen Intern Med ; 35(4): 1111-1119, 2020 04.
Article en En | MEDLINE | ID: mdl-31974903
BACKGROUND: Most patients with substance use disorders (SUDs) never receive treatment and SUDs are under-recognized in primary care (PC) where patients can be treated or linked to treatment. Asking PC patients to directly report SUD symptoms on questionnaires might help identify SUDs but to our knowledge, this approach is previously untested. OBJECTIVE: To describe the prevalence and severity of DSM-5 SUD symptoms reported by PC patients as part of routine care. DESIGN: Cross-sectional study using secondary data. PARTICIPANTS: A total of 241,265 adult patients who visited one of 25 PC sites in an integrated health system in Washington state and had alcohol, cannabis, or other drug use screening documented in their EHRs (March 2015-July 2018) were included in main analyses if they had a positive screen for high-risk substance use defined as AUDIT-C score 7-12 points, or report of past-year daily cannabis use or any other drug use. MAIN MEASURES: The main outcome was number of SUD symptoms based on Diagnostic and Statistical Manual, 5th edition (DSM-5), reported on Symptom Checklists (0-11) for alcohol or other drugs: 2-3 mild; 4-5 moderate; 6-11 severe. RESULTS: Of screened patients, 16,776 (5.7%) reported high-risk use of alcohol (2.4%), cannabis (3.9%), and/or other drugs (1.7%), and 65.0-69.9% of those completed Symptom Checklists. Of those with high-risk alcohol use, 52.5% (95% CI 50.9-54.0%) reported ≥ 2 symptoms consistent with mild-severe alcohol use disorders. Of those reporting daily cannabis use, 29.8% (28.6-30.9%) reported ≥ 2 symptoms consistent with mild-severe SUDs. Of those reporting any other drug use, 37.5% (35.7-39.3%) reported ≥ 2 symptoms consistent with mild-severe SUDs. CONCLUSIONS AND RELEVANCE: Many PC patients who screened positive for high-risk substance use reported symptoms consistent with DSM-5 SUDs on self-report Symptom Checklists. Use of SUD Symptom Checklists could support PC providers in making SUD diagnoses and initiating discussions of substance use.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Alcoholismo Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: J Gen Intern Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / Alcoholismo Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: J Gen Intern Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos